EP1124851A1 - Hnovilr - Google Patents

Hnovilr

Info

Publication number
EP1124851A1
EP1124851A1 EP99971818A EP99971818A EP1124851A1 EP 1124851 A1 EP1124851 A1 EP 1124851A1 EP 99971818 A EP99971818 A EP 99971818A EP 99971818 A EP99971818 A EP 99971818A EP 1124851 A1 EP1124851 A1 EP 1124851A1
Authority
EP
European Patent Office
Prior art keywords
polypeptide
seq
identity
amino acid
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99971818A
Other languages
German (de)
English (en)
Inventor
Kristine Kay Kikly
David Michalovich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1124851A1 publication Critical patent/EP1124851A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5406—IL-4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5409—IL-5

Abstract

L'invention concerne les polypeptides et polynucléotides de HNOVILR et des procédés permettant de produire ces polypeptides par des techniques recombinantes. L'invention concerne également des traitements comprenant l'utilisation de polypeptides et de polynucléotides de HNOVILR, et des tests diagnostiques portant sur ces derniers.
EP99971818A 1998-11-06 1999-11-01 Hnovilr Withdrawn EP1124851A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US187711 1980-09-16
US18771198A 1998-11-06 1998-11-06
PCT/US1999/025617 WO2000027882A1 (fr) 1998-11-06 1999-11-01 Hnovilr

Publications (1)

Publication Number Publication Date
EP1124851A1 true EP1124851A1 (fr) 2001-08-22

Family

ID=22690153

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99971818A Withdrawn EP1124851A1 (fr) 1998-11-06 1999-11-01 Hnovilr

Country Status (2)

Country Link
EP (1) EP1124851A1 (fr)
WO (1) WO2000027882A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
US7198789B2 (en) 1998-03-17 2007-04-03 Genetics Institute, Llc Methods and compositions for modulating interleukin-21 receptor activity
EP1230368A2 (fr) * 1999-11-18 2002-08-14 Schering Corporation Proteines de recepteurs mammaliens, reactifs et procedes s'y rapportant
EP1432431B1 (fr) * 2001-10-04 2017-05-10 Genetics Institute LLC Procedes et compositions permettant de moduler l'activite de l'interleukine-21
WO2004007682A2 (fr) 2002-07-15 2004-01-22 Wyeth Techniques et compositions permettant de moduler la fonction et le developpement de cellules assistantes (th)
RU2005131852A (ru) 2003-03-14 2006-04-20 Уайт (Us) Антитела против человеческого рецептора il-21 и их применение

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0027882A1 *

Also Published As

Publication number Publication date
WO2000027882A1 (fr) 2000-05-18

Similar Documents

Publication Publication Date Title
EP1085897A1 (fr) Acrp30r1l, homologue de acrp30 (proteine associee a un complement de l'adipocyte 30 kd)
US7214772B2 (en) Sialoadhesin family member-2 (SAF-2)
EP1003780A1 (fr) Antigene f11 humain, constituant un recepteur de surface cellulaire implique dans l'agregation plaquettaire
US20010011077A1 (en) Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides
EP1124851A1 (fr) Hnovilr
US20010025022A1 (en) Hnovilr
EP0869178A1 (fr) SAF-3, un membre de la famille des sialoadhésines
WO1999047658A1 (fr) Ef-7 un membre de la famille des cytokines
EP0911391A2 (fr) Clone HWHHJ20
EP1064364A1 (fr) Element 2-21 de la famille des cytokines
US20010049121A1 (en) Cytokine family member, 2-19
WO2001040247A1 (fr) Homologue d'interleukine-1, mat il-1h4
WO2000004923A1 (fr) Scrp-5: proteines-5 secretees riches en cysteine
EP0983078A1 (fr) Adnc de la famille des sialoadhesines 4 (saf-4)
EP1066317A2 (fr) Nouveaux composes
EP1007678A1 (fr) Kringle 1
WO2000017349A1 (fr) GENE HsgIII HUMAIN
EP1083923A1 (fr) Acrp30r1: homologue d'acrp30 (proteine liee au complement d'adipocyte 30 kd)
WO2000034470A1 (fr) Npcbac06: gene humain de l'atpase du reticulum endoplasmique de transition
WO2000058353A1 (fr) Npcahh01: gene humain de la proteine transmembranaire e3-16
WO2000034328A1 (fr) Tpaaoh04: gene humain sara de la proteine g
EP1107774A1 (fr) Ramp2a: proteine 2a modifiant l'activite d'un recepteur
WO2000021992A1 (fr) Proteine de liaison humaine fk506 (fkbp)
WO1999018990A1 (fr) Proteine 3 associee au recepteur de il-1
WO2000022116A1 (fr) Gene humain mdg1 (cbfawb10)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010606

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RBV Designated contracting states (corrected)

Designated state(s): GB

REG Reference to a national code

Ref country code: DE

Ref legal event code: 8566

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01N 33/50 B

Ipc: 7C 07K 16/28 B

Ipc: 7C 12N 5/10 B

Ipc: 7C 07K 14/715 B

Ipc: 7C 12N 15/12 A

18D Application deemed to be withdrawn

Effective date: 20040601

R18D Application deemed to be withdrawn (corrected)

Effective date: 20040601